Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1290110
Max Phase: Preclinical
Molecular Formula: C23H26O4
Molecular Weight: 366.46
Molecule Type: Small molecule
Associated Items:
ID: ALA1290110
Max Phase: Preclinical
Molecular Formula: C23H26O4
Molecular Weight: 366.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)c1cc2ccc(=O)oc2cc1OCCC12CC3CC(CC(C3)C1)C2
Standard InChI: InChI=1S/C23H26O4/c1-14(24)19-9-18-2-3-22(25)27-20(18)10-21(19)26-5-4-23-11-15-6-16(12-23)8-17(7-15)13-23/h2-3,9-10,15-17H,4-8,11-13H2,1H3
Standard InChI Key: WUBVIVKBXNEORA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.46 | Molecular Weight (Monoisotopic): 366.1831 | AlogP: 4.98 | #Rotatable Bonds: 5 |
Polar Surface Area: 56.51 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.90 | CX LogD: 3.90 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: 0.13 |
1. Maresca A, Scozzafava A, Supuran CT.. (2010) 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range., 20 (24): [PMID:21067924] [10.1016/j.bmcl.2010.10.094] |
Source(1):